What's happening
Live detector signal
Generated 00:51 ET
SKYE — Skye Bioscience, Inc. Common Stock is up 11.6%, at 0.77, on $1.2M traded, 56.4× 20-day volume, 0.07× float rotation. Score 72. Primary driver: 6.9% float rotation. Supply intelligence: mixed supply · 64.
Get alerts on $SKYE
Halts, resumptions, new filings, and updated reports — in your inbox within minutes of the event.
Free · one email per event, no digests or spam · unsubscribe anytime · joins real followers
Free float
—, refreshing
2026-08-18
Shares out
4.4M
latest detail
Market cap
$3.7M
at ref price
Short interest
0.6%
2026-10-30
Float rotation
0.07×
latest snapshot
20d dollar vol
$105.7K
baseline
Gap quality
mixed supply · 64
live supply-pressure model
Supply factor
positive gap demand
detector reason
Supply factor
nano-cap supply profile
detector reason
This estimates whether a gap is clean, squeeze-prone, mixed, or supply-heavy using float, float rotation, short interest, market cap, split risk, and live volume. Registered resale/ATM exhaustion is a planned deeper parser layer.
2026-11-10 13:55 ETSignalSkye Bioscience, Inc. Common Stock is up 11.6%, at 0.77, on $1.2M traded, 56.4× 20-day volume, 0.07× float rotation. Score 72. Primary driver: 6.9% float rotation. Supply intelligence: mixed supply · 64.
2026-09-118-KItem 1.02 — Termination of a material definitive agreement; Item 5.02 — Director or officer departure/election/appointment +1 more SEC
2026-08-24Split1-for-8 reverse split logged
2026-08-248-KItem 1.01 — Entry into a material definitive agreement; Item 3.02 — Unregistered sales of equity securities +1 more SEC
2026-08-148-KItem 1.01 — Entry into a material definitive agreement; Item 3.02 — Unregistered sales of equity securities +1 more SEC
2026-01-29 07:00 ETFDA / ClinicalSkye Bioscience Highlights Attributes of its Peripherally-restricted CB1 Inhibitor Antibody at Keystone Obesity Conference News
2026-01-15 19:00 ETFDA / ClinicalLevi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Skye Bioscience, Inc.(SKYE) Shareholders News
2026-01-15 14:58 ETFDA / ClinicalSKYE DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important January 16 Deadline in Securities Class Action – SKYE News
2026-01-15 14:50 ETLegalJYD DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Jayud Global Logistics Ltd. Investors to Secure Counsel Before Important January 20 Deadline in Securities Class Action - JYD News
Latest detector signalscore 72